DUBLIN, March 18, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, continues to make progress in increasing ventilator production worldwide. The company...
Medtronic recognizes the acute need for ventilators as life-saving devices in the management of COVID-19 infections. High-performance ventilators play a critical role in the management of patients with severe respiratory illness, such as COVID-19, who require assistance because they cannot breathe effectively. By placing a patient on such a ventilator, the patient’s lungs are permitted to rest and recover while the ventilator performs the functions of supplying oxygen and simulating the actions of breathing. Without ventilation support, some patients with severe respiratory disease might not survive.
Medtronic is an industry leader in respiratory care and device innovation. The company produces high performance ventilators for a variety of care settings, including the acute segment (in-hospital patients in intensive care units, emergency departments or on the general care floors) and the sub-acute segment (out of hospital, long-term care facilities or home-ventilated patients). Medtronic manufactures the Puritan Bennett™ 980 (PB 980) and Puritan Bennett™ 840 (PB 840) high performance ventilators in Galway,
Medtronic Demand and Supply
Ventilator demand has significantly increased in light of COVID-19, and Medtronic continues to work to meet this increased global demand. Ventilator manufacturing is a complex process that relies on a skilled workforce, a global supply chain and a rigorous regulatory regime to ensure patient safety.
In recent weeks, Medtronic has identified additional opportunities to further increase its ventilator manufacturing capacity. In the company’s
Medtronic is prioritizing high risk/high needs areas for ventilator allocation on a weekly basis for global distribution through its supply chain. COVID-19 is a dynamic global issue, and Medtronic will continue to monitor the situation and provide updates to its employees, customers and investors as the situation warrants.
“Medtronic recognizes the demand for ventilators in this environment has far outstripped supply,” said
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the
Source: Medtronic plc